IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $143,445,591 | -9.2% | 14,895,700 | +0.3% | 0.00% | 0.0% |
| Q2 2023 | $157,967,186 | +0.3% | 14,846,540 | -0.9% | 0.00% | 0.0% |
| Q1 2023 | $157,529,803 | -13.7% | 14,974,316 | +1.6% | 0.00% | -20.0% |
| Q4 2022 | $182,536,530 | +21.6% | 14,732,569 | +1.7% | 0.01% | +25.0% |
| Q3 2022 | $150,060,000 | -10.1% | 14,484,557 | +0.0% | 0.00% | -20.0% |
| Q2 2022 | $166,952,000 | -0.6% | 14,479,824 | +8.4% | 0.01% | +25.0% |
| Q1 2022 | $168,023,000 | +6.8% | 13,356,328 | -1.0% | 0.00% | 0.0% |
| Q4 2021 | $157,268,000 | -10.5% | 13,487,762 | +0.2% | 0.00% | 0.0% |
| Q3 2021 | $175,737,000 | -1.7% | 13,456,133 | -3.2% | 0.00% | 0.0% |
| Q2 2021 | $178,857,000 | +1.9% | 13,897,179 | -11.5% | 0.00% | -20.0% |
| Q1 2021 | $175,501,000 | -3.0% | 15,697,720 | -1.2% | 0.01% | 0.0% |
| Q4 2020 | $181,015,000 | +27.7% | 15,892,347 | +0.8% | 0.01% | 0.0% |
| Q3 2020 | $141,748,000 | -16.1% | 15,758,418 | -3.7% | 0.01% | -16.7% |
| Q2 2020 | $168,901,000 | +2.4% | 16,366,337 | +0.2% | 0.01% | -14.3% |
| Q1 2020 | $164,882,000 | -25.5% | 16,341,190 | -1.8% | 0.01% | -12.5% |
| Q4 2019 | $221,464,000 | +54.1% | 16,638,941 | -0.6% | 0.01% | +60.0% |
| Q3 2019 | $143,759,000 | -15.8% | 16,745,173 | +7.3% | 0.01% | -16.7% |
| Q2 2019 | $170,730,000 | -15.5% | 15,606,157 | +4.5% | 0.01% | -25.0% |
| Q1 2019 | $202,155,000 | +46.0% | 14,941,264 | +11.8% | 0.01% | +33.3% |
| Q4 2018 | $138,415,000 | -39.2% | 13,360,554 | +8.4% | 0.01% | -33.3% |
| Q3 2018 | $227,518,000 | -0.4% | 12,324,954 | +3.2% | 0.01% | -10.0% |
| Q2 2018 | $228,441,000 | +29.0% | 11,947,777 | +4.1% | 0.01% | +25.0% |
| Q1 2018 | $177,141,000 | +4.8% | 11,480,383 | +1.8% | 0.01% | +14.3% |
| Q4 2017 | $169,010,000 | -2.7% | 11,274,790 | +2.4% | 0.01% | -12.5% |
| Q3 2017 | $173,718,000 | -14.5% | 11,015,722 | +2.4% | 0.01% | -20.0% |
| Q2 2017 | $203,184,000 | +13.4% | 10,761,867 | +2.4% | 0.01% | +11.1% |
| Q1 2017 | $179,223,000 | +17.9% | 10,505,461 | +5.7% | 0.01% | +12.5% |
| Q4 2016 | $152,034,000 | -0.9% | 9,943,282 | +3.0% | 0.01% | -11.1% |
| Q3 2016 | $153,374,000 | +25.1% | 9,658,333 | +3.0% | 0.01% | +12.5% |
| Q2 2016 | $122,637,000 | +23.2% | 9,379,525 | +3.1% | 0.01% | +33.3% |
| Q1 2016 | $99,531,000 | -2.5% | 9,097,867 | +3.3% | 0.01% | -14.3% |
| Q4 2015 | $102,117,000 | -42.7% | 8,810,823 | -48.5% | 0.01% | 0.0% |
| Q3 2015 | $178,162,000 | +77.7% | 17,098,216 | +105.6% | 0.01% | 0.0% |
| Q2 2015 | $100,272,000 | -21.6% | 8,314,442 | +4.0% | 0.01% | -22.2% |
| Q1 2015 | $127,965,000 | +10.7% | 7,997,806 | +6.0% | 0.01% | +12.5% |
| Q4 2014 | $115,570,000 | +21.9% | 7,543,747 | +3.1% | 0.01% | +14.3% |
| Q3 2014 | $94,781,000 | -14.1% | 7,316,217 | +1.6% | 0.01% | -22.2% |
| Q2 2014 | $110,388,000 | +25.4% | 7,200,806 | +0.8% | 0.01% | +28.6% |
| Q1 2014 | $88,037,000 | +33.8% | 7,145,775 | +26.1% | 0.01% | +16.7% |
| Q4 2013 | $65,802,000 | +1.1% | 5,667,775 | +3.2% | 0.01% | 0.0% |
| Q3 2013 | $65,088,000 | +26.9% | 5,492,634 | +6.6% | 0.01% | +20.0% |
| Q2 2013 | $51,272,000 | – | 5,152,947 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |